Rho Kinase Inhibitors [MoA] - N0000193789

Name: Table of NDC products with rho kinase inhibitors
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000193789
Pharmacologic Name	Rho Kinase Inhibitors
Pharmacologic Uses	Rho kinase inhibitor
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Rho Kinase Inhibitors

The table contains 2 products whose active ingredient are classified under the same pharmacologic class Rho Kinase Inhibitors [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	70727-497	Rhopressa	Non-Proprietary Name: Netarsudil	Solution/ Drops	Ophthalmic; Topical	Alcon Laboratories, Inc.	ACTIVE
	70727-529	Rocklatan	Non-Proprietary Name: Netarsudil And Latanoprost Ophthalmic Solution, 0.02%/0.005%	Solution/ Drops	Ophthalmic; Topical	Alcon Laboratories, Inc.	ACTIVE